Ranitidine bismuth citrate - CAS 128345-62-0

Ranitidine bismuth citrate, an orally administered Histamine H2-receptor antagonist, demonstrates a potent inhibitory concentration (IC 50) of 3.3 μM and exhibits high selectivity towards SARS-CoV-2-infected cells. It is widely utilized as an anti-Helicobacter pylori agent, exhibiting a minimum inhibitory concentration (MIC 90) value of 16 ng/L.

Others, Histamine Receptor, SARS-CoV, Antibacterial

Neuroscience, Microbiology/Virology, GPCR/G Protein, Immunology/Inflammation, Others

128283

C19H27BiN4O10S

712.48

O=C(O)CC(O)(C(=O)O)CC(=O)O.O=N(=O)C=C(NC)NCCSCC=1OC(=CC1)CN(C)C.[BiH3]

-20°C

Ice Packs

Small Compound